Androgenetic hair loss in men and women. Modern methods of rapid recovery. Real results in practice (before and after).
Androgenetic alopecia is an increased hair loss leading to complete baldness. This type of disease is more common in men. But doctors - trichologists note that in recent years, male pattern baldness has been found in more than 40% of patients who have applied to them.
Androgenetic alopecia in women proceeds differently than in men - the hairline is preserved in the forehead, the loss is uniform within the fronto-parietal zone and not so pronounced.
There are three models of androgenetic alopecia:
- Hamilton model - thinning and thinning of hair in the parietal zone and expansion of the frontotemporal angles, rather characteristic of men, which is observed in women in menopause or with hyperandrogenism;
- Ludwig model - extensive thinning of the hair within the crown with the preservation of the hairline in the forehead;
- Olsen model or "Christmas tree" - thinning and thinning of the hair of the central part of the head with a lesion of the hairline in the forehead.
⠀
After examining 468 patients, the German dermatologist Ludwig identified three degrees of hair thinning in the fronto-parietal zone:
- Noticeable thinning of the hair and expansion of the parting.
- Marked thinning of the hair.
- Hair is completely lost (occurs in less than 5% of women)
Complications of androgenetic alopecia (baldness in women).
The main complication of androgenetic alopecia in women is the complete loss of hair without the possibility of their natural restoration. Hair loss does not lead to loss of working capacity, deterioration of the general condition and does not require a long stay in the hospital. However, hair loss worsens the emotional state of patients and affects the quality of life. Patients may suffer from mild forms of anxiety, depressive and sociophobic disorders.⠀
Diagnosis of androgenetic alopecia.
For early detection and differential diagnosis with other alopecia, dermatoscopy is performed. Dermatoscopic signs of androgenetic alopecia are anisotrichosis (variability in diameters of more than 20% due to thinning hair), peripapillary signs (brown halo around the follicle, yellow dots), and an increase in the number of vellus-like hairs.
When diagnosing, it is important to evaluate the function of the thyroid gland, the level of ferritin, zinc, vitamin D and prolactin. This is necessary to eliminate factors that can increase hair loss and aggravate the disease.
Patients with a history of irregular menstruation, an elevated body mass index, or skin signs of hyperandrogenism should be referred to an endocrinologist for possible PCOS (polycystic ovary syndrome) and HCHD (congenital adrenal dysfunction).
Clinical example 1.
48 year old woman, hair loss since 30. Diagnosis: androgenetic hair loss, stage 2-3 according to Ludwig.⠀
Women's hair fall A 48-year-old woman complained of severe hair loss on the top of her head.
Diagnosis: androgenetic hair loss, stage 2-3 according to Ludwig Diagnostics:
-Phototrichogram study showed:⠀
1. More than 4 yellow dots in four fields at a magnification of 70 times.⠀
2. The average thickness of the hair in the frontal zone than in the occipital zone when counting is not less than 50 hairs.⠀
3. More than 10% vellus hairs (less than 30 µm in diameter) in the anterior zone.
⠀
- Laboratory diagnostics of blood
Appointments:
There is a new treatment for androgenetic hair loss in our practice: Treatment regimen:
1. Preparation with Resedaodor scalp cleansing peeling according to the protocol once a week, in multiples of 6
2. Apply ResedaOdor SCC5 Lotion morning and evening. Appointment for 4 months
3. Hair loss shampoo without sls sles with niacinamide, capixil, biotin and a complex of 11 vitamins and trace elements
⠀⠀
Conclusion.
⠀ Androgenetic alopecia is a chronic disease and progresses without treatment. Minoxidil 2% is currently the officially recognized worldwide treatment for AGA in women. If patients start treatment with minoxidil, then it should be lifelong, since withdrawal syndrome develops upon discontinuation. You should also be aware that this drug, like most antiandrogenic drugs, is not used in pregnant and lactating women.
The active substances scc5 capixil and procopil have been shown to be more effective than minoxidil, safer and without withdrawal symptoms in comparative placebo-controlled studies conducted in independent laboratories. And an important point, the appointment of scc5 can level the minoxidil withdrawal syndrome during co-administration or transfer of the patient, due to signal peptides that stimulate the production of extracellular matrix peptides, such as laminin and type III and VII collagen.
It is important to remember that for effective therapy, one should work with drugs with a therapeutic dose of active ingredients, then we can be sure of achieving a result. Resedaodor is a company that always adheres to this rule and can be a conscientious partner of the trichologist in solving the problem of hair and scalp.